Risk score · Cancer
Ovarian Cancer Polygenic Risk Score
Epithelial ovarian cancer is the most common form of ovarian cancer. Rare variants such as BRCA1 and BRCA2 carry most inherited risk; this score captures the common ones.
A risk score adds up many common variants, each with a small effect, into an estimate of genetic predisposition. It is not a diagnosis.
A polygenic score for Invasive epithelial ovarian cancer
Genetic variants
- 30
Method
- Genome-wide significant variants
Built from studies of
- European 100%
Evaluated in
- European 100%
Published
Barnes DR et al. (2020). Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genet Med.
References
- Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, 2016. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discov
- Phelan CM, Kuchenbaecker KB, Tyrer JP, Kar SP, Lawrenson K, Winham SJ, 2017. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat Genet
Other cancer risk scores
- Basal Cell Carcinoma
- Bladder Cancer
- Chronic Lymphocytic Leukaemia (CLL)
- Colorectal Cancer
- Glioma
- Lung Cancer
- Melanoma
- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Pancreatic Cancer
- Prostate Cancer
One test. A lifetime of answers.
One kit, sent to your home. Your entire genome sequenced at the clinical standard used for diagnostic decisions. Physician-ready reports delivered to your Genome Manager in 6–8 weeks — permanent and updated as science advances.
Free shipping · Results in 6–8 weeks
Premium adds $99 per kit for the first year.
